On top of that, in WHO CNS5 EGFR gene amplification is one of the criteria to upgrade IDH-wildtype diffuse astrocytic tumor in adults to glioblastoma, IDH-wildtype [1]. This evidence concerns the gene IDH1 and glioblastoma.